Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells-Reference-Cited by-同舟云学术

Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells

Published:2009-09 Issue:2 Volume:33 Page:135-140
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Donia Marco,Mangano Katia,Amoroso Alfredo,Mazzarino Maria Clorinda,Imbesi Rosa,Castrogiovanni Paola,Coco Marinella,Meroni PierLuigi,Nicoletti Ferdinando

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Regulatory T cells in human autoimmune diseases;Torgerson;Springer Semin Immunopathol,2006

2. Regulatory T cells: development, function and role in autoimmunity;Lan;Autoimmun Rev,2005

3. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells;Battaglia;Blood,2005

4. Role for suppressor T cells in the pathogenesis of autoimmune diseases (including rheumatoid arthritis). Facts and hypotheses;Berthelot;Joint Bone Spine,2004

5. The role of regulatory T cells in multiple sclerosis;Zozulya;Nat Clin Pract Neurol,2008

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapamycin rescues loss of function in blood-brain barrier–interacting Tregs;JCI Insight;2024-04-08

2. Huangqi-Guizhi-Wuwu decoction regulates differentiation of CD4+ T cell and prevents against experimental autoimmune encephalomyelitis progression in mice;Phytomedicine;2024-03

3. CD8+iTregs mediate the protective effect of rapamycin against graft versus host disease in a humanized murine model;Transplant Immunology;2023-04

4. FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders;Pharmaceuticals;2022-12-13

5. Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention;Clinical Immunology;2022-12